BAJAJ BROKING

Notification close image
No new Notification messages
card image
Crizac IPO is Open!
Apply for the Crizac IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

14296

512529

SEQUENT

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SEQUENT SCIENTIFIC LTD. performance

Today’s low

Today’s high

₹ 184.01 ₹ 188.51
₹ 185.12

52 week low

52 week high

₹ 117.35 ₹ 240.70
₹ 185.12

Open Price

₹ 185.05

Prev. Close

₹ 185.31

Volume (Shares)

163821.00

Total traded value

₹ 303.26

Upper Circuit

₹ 222.37

Lower Circuit

₹ 148.24

info

SEQUENT SCIENTIFIC LTD. Share Price Update

As of the latest trading session, SEQUENT SCIENTIFIC LTD. share price is currently at ₹ 185.27, which is down by ₹ -0.03 from its previous closing. Today, the stock has fluctuated between ₹ 184.01 and ₹ 188.51. Over the past year, SEQUENT SCIENTIFIC LTD. has achieved a return of 48.01 %. In the last month alone, the return has been -6.26 %. Read More...

Investment Returns

Over 1 Month -6.26% Over 3 Months 35.13% Over 6 Months -4.42% Over 1 Year 48.01%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SEQUENT SCIENTIFIC LTD. fundamentals


  • Market cap (Cr)

    4,630.60

  • P/E Ratio (TTM)

    294.29

  • Beta

    1.49

  • Book Value / share

    45.65

  • Return on equity

    0.22%

  • EPS (TTM)

    0.77

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    4.23

info icon alternate text
  • Market cap (Cr)

    4,639.40

  • P/E Ratio (TTM)

    294.29

  • Beta

    1.35

  • Book Value / share

    45.65

  • Return on equity

    0.22%

  • EPS (TTM)

    0.77

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    4.23

info icon alternate text

SEQUENT SCIENTIFIC LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 42.33
Operating Expense 48.44
Net Profit 4.23
Net Profit Margin (%) 9.99
Earnings Per Share (EPS) 0.17
EBITDA 9.20
Effective Tax Rate (%) 28.42
Particulars DEC 2024 (Values in Cr)
Revenue 36.27
Operating Expense 44.16
Net Profit 2.81
Net Profit Margin (%) 7.74
Earnings Per Share (EPS) 0.11
EBITDA 7.09
Effective Tax Rate (%) 23.64
Particulars SEP 2024 (Values in Cr)
Revenue 41.99
Operating Expense 47.21
Net Profit 4.26
Net Profit Margin (%) 10.14
Earnings Per Share (EPS) 0.17
EBITDA 9.53
Effective Tax Rate (%) 33.54
Particulars JUN 2024 (Values in Cr)
Revenue 57.67
Operating Expense 62.46
Net Profit 4.50
Net Profit Margin (%) 7.80
Earnings Per Share (EPS) 0.18
EBITDA 8.86
Effective Tax Rate (%) 25.61
Particulars MAR 2024 (Values in Cr)
Revenue 36.77
Operating Expense 45.65
Net Profit 3.76
Net Profit Margin (%) 10.22
Earnings Per Share (EPS) 0.15
EBITDA 7.21
Effective Tax Rate (%) 8.29
Particulars MAR 2025 (Values in Cr)
Revenue 178.26
Operating Expense 202.27
Net Profit 15.80
Net Profit Margin (%) 8.86
Earnings Per Share (EPS) 0.63
EBITDA 34.68
Effective Tax Rate (%) 28.34
Particulars MAR 2024 (Values in Cr)
Revenue 168.52
Operating Expense 208.48
Net Profit 0.63
Net Profit Margin (%) 0.37
Earnings Per Share (EPS) 0.03
EBITDA 13.07
Effective Tax Rate (%) 373.91
Particulars MAR 2023 (Values in Cr)
Revenue 222.69
Operating Expense 260.67
Net Profit -6.08
Net Profit Margin (%) -2.73
Earnings Per Share (EPS) -0.24
EBITDA 1.87
Effective Tax Rate (%) 37.64
Particulars MAR 2022 (Values in Cr)
Revenue 219.63
Operating Expense 231.58
Net Profit 14.80
Net Profit Margin (%) 6.73
Earnings Per Share (EPS) 0.60
EBITDA 26.89
Effective Tax Rate (%) 5.67
Particulars MAR 2021 (Values in Cr)
Revenue 265.46
Operating Expense 241.97
Net Profit 32.11
Net Profit Margin (%) 12.09
Earnings Per Share (EPS) 1.30
EBITDA 52.70
Effective Tax Rate (%) 21.44
Particulars MAR 2024 (Values in Cr)
Book Value / Share 26.32
ROE % -3.09
ROCE % 0.45
Total Debt to Total Equity 0.69
EBITDA Margin 4.88
Particulars MAR 2023 (Values in Cr)
Book Value / Share 28.01
ROE % -9.04
ROCE % -3.52
Total Debt to Total Equity 0.58
EBITDA Margin 1.14
Particulars MAR 2022 (Values in Cr)
Book Value / Share 27.50
ROE % 6.31
ROCE % 6.57
Total Debt to Total Equity 0.45
EBITDA Margin 8.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.30
ROE % 13.98
ROCE % 14.62
Total Debt to Total Equity 0.44
EBITDA Margin 15.54
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.66
ROE % 10.17
ROCE % 10.78
Total Debt to Total Equity 0.48
EBITDA Margin 15.30
Particulars MAR 2024 (Values in Cr)
Book Value / Share 43.59
ROE % 0.22
ROCE % 0.52
Total Debt to Total Equity 0.03
EBITDA Margin 8.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 42.43
ROE % -0.58
ROCE % -0.68
Total Debt to Total Equity 0.02
EBITDA Margin 0.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 41.55
ROE % 1.43
ROCE % 1.65
Total Debt to Total Equity 0.01
EBITDA Margin 12.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 41.45
ROE % 3.27
ROCE % 4.34
Total Debt to Total Equity 0.02
EBITDA Margin 19.85
Particulars MAR 2020 (Values in Cr)
Book Value / Share 35.68
ROE % 2.23
ROCE % 2.79
Total Debt to Total Equity 0.04
EBITDA Margin 16.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 69.83
Total Assets 1540.38
Total Liabilities 1540.38
Total Equity 712.95
Share Outstanding 249433495
Price to Book Ratio 2.65
Return on Assets (%) -2.32
Return on Capital (%) -3.08
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 41.74
Total Assets 1529.12
Total Liabilities 1529.12
Total Equity 749.19
Share Outstanding 249433495
Price to Book Ratio 1.71
Return on Assets (%) -7.92
Return on Capital (%) -10.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 59.25
Total Assets 1450.97
Total Liabilities 1450.97
Total Equity 740.10
Share Outstanding 248370995
Price to Book Ratio 3.22
Return on Assets (%) 2.82
Return on Capital (%) 3.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 56.19
Total Assets 1392.55
Total Liabilities 1392.55
Total Equity 776.31
Share Outstanding 248370995
Price to Book Ratio 5.81
Return on Assets (%) 6.85
Return on Capital (%) 9.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 75.82
Total Assets 1462.64
Total Liabilities 1462.64
Total Equity 731.84
Share Outstanding 248370995
Price to Book Ratio 2.18
Return on Assets (%) 4.77
Return on Capital (%) 6.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.95
Total Assets 1187.59
Total Liabilities 1187.59
Total Equity 1087.22
Share Outstanding 249433495
Price to Book Ratio 2.65
Return on Assets (%) 0.05
Return on Capital (%) 0.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 1122.77
Total Liabilities 1122.77
Total Equity 1058.36
Share Outstanding 249433495
Price to Book Ratio 1.71
Return on Assets (%) -0.54
Return on Capital (%) -0.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.88
Total Assets 1124.23
Total Liabilities 1124.23
Total Equity 1041.08
Share Outstanding 248370995
Price to Book Ratio 3.22
Return on Assets (%) 1.31
Return on Capital (%) 1.4
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.74
Total Assets 1102.12
Total Liabilities 1102.12
Total Equity 1029.51
Share Outstanding 248370995
Price to Book Ratio 5.81
Return on Assets (%) 2.91
Return on Capital (%) 3.1
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.71
Total Assets 997.37
Total Liabilities 997.37
Total Equity 886.21
Share Outstanding 248370995
Price to Book Ratio 2.18
Return on Assets (%) 2.13
Return on Capital (%) 2.33
Particulars MAR 2024 (Values in Cr)
Net Income -54.64
Cash from Operations 44.65
Cash from Investing -5.92
Cash from Financing -1.43
Net change in Cash 23.23
Free Cash Flow 75.45
Particulars MAR 2023 (Values in Cr)
Net Income -137.65
Cash from Operations 31.45
Cash from Investing -64.95
Cash from Financing 32.22
Net change in Cash -15.92
Free Cash Flow 117.63
Particulars MAR 2022 (Values in Cr)
Net Income 52.93
Cash from Operations 57.36
Cash from Investing -95.56
Cash from Financing 67.25
Net change in Cash 2.28
Free Cash Flow 89.82
Particulars MAR 2021 (Values in Cr)
Net Income 145.45
Cash from Operations 158.54
Cash from Investing 9.64
Cash from Financing -138.75
Net change in Cash -14.35
Free Cash Flow 211.37
Particulars MAR 2020 (Values in Cr)
Net Income 94.07
Cash from Operations 127.18
Cash from Investing -72.27
Cash from Financing -42.75
Net change in Cash 0.30
Free Cash Flow 167.90
Particulars MAR 2024 (Values in Cr)
Net Income -0.23
Cash from Operations -29.19
Cash from Investing 5.47
Cash from Financing 22.31
Net change in Cash 0.84
Free Cash Flow -19.66
Particulars MAR 2023 (Values in Cr)
Net Income -9.74
Cash from Operations 38.44
Cash from Investing -50.70
Cash from Financing 0.24
Net change in Cash -12.71
Free Cash Flow 47.30
Particulars MAR 2022 (Values in Cr)
Net Income 15.69
Cash from Operations 11.11
Cash from Investing -4.24
Cash from Financing 7.24
Net change in Cash 12.36
Free Cash Flow 17.56
Particulars MAR 2021 (Values in Cr)
Net Income 43.44
Cash from Operations 19.09
Cash from Investing 16.55
Cash from Financing -21.32
Net change in Cash -2.43
Free Cash Flow 28.61
Particulars MAR 2020 (Values in Cr)
Net Income 22.81
Cash from Operations 32.39
Cash from Investing -17.68
Cash from Financing -10.71
Net change in Cash 1.80
Free Cash Flow 37.78
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.52 27.88 1.99 279.86 34.11 / 77.70
BLISS GVS PHARMA LTD 155.10 19.39 1.55 1634.29 103.00 / 184.95
CIPLA LTD 1497.25 23.50 3.87 120934.05 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 332.25 12.72 2.69 977.84 163.50 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.52 36.52 5.77 279.86 34.11 / 77.70
AMRUTAJAN HEALTH LTD 717.30 40.80 6.34 2073.76 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 9018.30 128.80 29.26 22545.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 155.10 23.68 1.54 1634.29 103.00 / 184.95

SEQUENT SCIENTIFIC LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
186.39 0.58 redarrow
red-green-graph indicator
9 Bearish
7 Bullish
  • 5 Days 188.20
  • 26 Days 187.20
  • 10 Days 189.10
  • 50 Days 180.10
  • 12 Days 189.20
  • 100 Days 172.70
  • 20 Days 188.60
  • 200 Days 166.20
185.91 PIVOT

First Support

183.30

First Resistance

187.91

Second Support

181.30

Second Resistance

190.52

Third Support

178.69

Third Resistance

192.52

RSI

48.38

ADX

24.87

MACD

2.02

Williams % R

-84.08

Commodity Channel Index (CCI)

-115.29

Date

2025-07-02

Week

242986.00

Same Day

146661.00

Month

284818.00

1 Year

1.50

3 Year

1.08

Over 1 Month

-6.26%

down

Over 1 Year

48.01%

down

Over 3 Months

35.13%

down

Over 3 Years

24.08%

down

Over 6 Months

-4.42%

down

Over 5 Years

14.24%

down

SEQUENT SCIENTIFIC LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
28.52%
Promoter Holdings
52.6%
FII
6.04%
DII
12.82%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Ca Harbor Investments 1.31680103E8 (52.61%) Shareholding of Promoter and Promoter Group
Quant Mutual Fund - Quant Healthcare Fund 2.384837E7 (9.53%) Public Shareholding
Ashoka Whiteoak Icav - Ashoka Whiteoak India Oppor 3694299.0 (1.48%) Public Shareholding

News

Left Arrow
Right Arrow

SEQUENT SCIENTIFIC LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
08 Sep 2021 0.5 Final 10 Sep 2021 Equity shares
21 Aug 2019 0.2 Final 23 Aug 2019 Equity shares
20 Nov 2017 0.2 Interim 21 Nov 2017 Equity shares
16 Sep 2011 1.5 Final 20 Sep 2011 Equity shares
23 Sep 2010 2.0 Final 27 Sep 2010 Equity shares
02 Sep 2009 1.0 Final 04 Sep 2009 Equity shares
11 Sep 2008 1.0 Final 15 Sep 2008 Equity shares
13 Sep 2007 1.0 Final 17 Sep 2007 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
25 Feb 2016 10.0 2.0 26 Feb 2016
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
08 Sep 2021 0.5 Final 10 Sep 2021 Equity shares
21 Aug 2019 0.2 Final 23 Aug 2019 Equity shares
20 Nov 2017 0.2 Interim 21 Nov 2017 Equity shares
16 Sep 2011 1.5 Final 20 Sep 2011 Equity shares
23 Sep 2010 2.0 Final 27 Sep 2010 Equity shares
02 Sep 2009 1.0 Final 04 Sep 2009 Equity shares
11 Sep 2008 1.0 Final 15 Sep 2008 Equity shares
13 Sep 2007 1.0 Final 17 Sep 2007 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
25 Feb 2016 10.0 2.0 26 Feb 2016

SEQUENT SCIENTIFIC LTD. Share Price

Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003.

Parent organization MNC Associate
NSE symbol SEQUENT
Founded 1985
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sequent Scientific Ltd?

Answer Field

Sequent Scientific Ltd share price is for NSE ₹ 185.27 & for BSE ₹ 185.25 as on Jul 03 2025 12:17 PM.

What is the Market Cap of Sequent Scientific Ltd Share?

Answer Field

The market cap of Sequent Scientific Ltd for NSE ₹ 4,621.25 & for BSE ₹ 4,620.75 as on Jul 03 2025 12:17 PM.

What is the 52 Week High and Low of Sequent Scientific Ltd?

Answer Field

The 52 Week High and Low of Sequent Scientific Ltd for NSE is ₹ 240.70 and ₹ 117.35 and for BSE is ₹ 240.90 and ₹ 111.00.

What is 1 year return for Sequent Scientific Ltd?

Answer Field

The 1 year returns on the stock has been 48.01%.

What is the P/E Ratio of Sequent Scientific Ltd Share?

Answer Field

As on Jul 03 2025 12:17 PM the price-to-earnings (PE) ratio for Sequent Scientific Ltd share is 294.29.

What is the PB ratio of Sequent Scientific Ltd Share?

Answer Field

As on Jul 03 2025 12:17 PM, the price-to-book (PB) ratio for Sequent Scientific Ltd share is 45.65.

How to Buy Sequent Scientific Ltd Share?

Answer Field

You can trade in Sequent Scientific Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sequent Scientific Ltd Share on Bajaj Broking App?

Answer Field

To buy Sequent Scientific Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sequent Scientific Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|